BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9918906)

  • 1. Association of diabetes mellitus and chronic hepatitis C virus infection.
    Mason AL; Lau JY; Hoang N; Qian K; Alexander GJ; Xu L; Guo L; Jacob S; Regenstein FG; Zimmerman R; Everhart JE; Wasserfall C; Maclaren NK; Perrillo RP
    Hepatology; 1999 Feb; 29(2):328-33. PubMed ID: 9918906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of hepatitis C virus infection in type 2 diabetic patients attending Plateau state specialist hospital Jos Nigeria.
    Ndako JA; Echeonwu GO; Shidali NN; Bichi IA; Paul GA; Onovoh E; Okeke LA
    Virol J; 2009 Jul; 6():98. PubMed ID: 19586535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and type 2 diabetes.
    Negro F; Alaei M
    World J Gastroenterol; 2009 Apr; 15(13):1537-47. PubMed ID: 19340895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes.
    Cheng YC; Lee TY; Li YH; Lu CL; Liu HC; Sheu ML; Lee IT
    Sci Rep; 2024 Feb; 14(1):4607. PubMed ID: 38409227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering potential pathways between type 2 diabetes mellitus and diabetic retinopathy: A big data analysis of the South Korean National Sample Cohort.
    Kim Y; Hyun C; Lee M
    Medicine (Baltimore); 2023 Aug; 102(31):e34576. PubMed ID: 37543803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection-Induction of Autoimmune Dysregulation and Metabolic Disturbances.
    Grubišić B; Švitek L; Ormanac K; Sabo D; Mihaljević I; Bilić-Ćurčić I; Omanović Kolarić T
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin.
    Chudhary HRF; Ali A; Bibi S; Waqas M; Rafique S; Idrees M; Halim SA; Abdellattif MH; Khan A; Al-Harrasi A
    ACS Omega; 2023 Apr; 8(16):14784-14791. PubMed ID: 37125127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Insulin in the Age of Precision Medicine and Big Data: Under-Explored Nature of Genomics.
    Cook TW; Wilstermann AM; Mitchell JT; Arnold NE; Rajasekaran S; Bupp CP; Prokop JW
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus.
    Angel M; Petrosyan Y; Doyle MA; Cooper C
    BMC Endocr Disord; 2022 Nov; 22(1):277. PubMed ID: 36371200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.
    Rajewski P; Zarębska-Michaluk D; Janczewska E; Gietka A; Mazur W; Tudrujek-Zdunek M; Tomasiewicz K; Belica-Wdowik T; Baka-Ćwierz B; Dybowska D; Halota W; Lorenc B; Sitko M; Garlicki A; Berak H; Horban A; Orłowska I; Simon K; Socha Ł; Wawrzynowicz-Syczewska M; Jaroszewicz J; Deroń Z; Czauż-Andrzejuk A; Citko J; Krygier R; Piekarska A; Laurans Ł; Dobracki W; Białkowska J; Tronina O; Wietlicka-Piszcz M; Pawłowska M; Flisiak R
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study.
    Pontual DM; Nabuco LC; Luiz RR; Cardoso AC; Perez RM; Villela-Nogueira CA
    Clinics (Sao Paulo); 2021; 76():e3236. PubMed ID: 34755761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-autoimmune diabetes mellitus and the risk of virus infections: a systematic review and meta-analysis of case-control and cohort studies.
    Lontchi-Yimagou E; Feutseu C; Kenmoe S; Djomkam Zune AL; Kinyuy Ekali SF; Nguewa JL; Choukem SP; Mbanya JC; Gautier JF; Sobngwi E
    Sci Rep; 2021 Apr; 11(1):8968. PubMed ID: 33903699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic complications of hepatitis C virus infection.
    Chaudhari R; Fouda S; Sainu A; Pappachan JM
    World J Gastroenterol; 2021 Apr; 27(13):1267-1282. PubMed ID: 33833481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus cascade of care in the general population, in people with diabetes, and in substance use disorder patients.
    Djuric O; Massari M; Ottone M; Collini G; Mancuso P; Vicentini M; Nicolaci A; Zannini A; Zerbini A; Manicardi V; Kondili LA; Giorgi Rossi P
    Infect Agent Cancer; 2021 Jan; 16(1):5. PubMed ID: 33468188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.
    Prestwood TR; Asgariroozbehani R; Wu S; Agarwal SM; Logan RW; Ballon JS; Hahn MK; Freyberg Z
    Behav Brain Res; 2021 Mar; 402():113101. PubMed ID: 33453341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A state of the art review on the novel mediator asprosin in the metabolic syndrome.
    Luís C; Fernandes R; Soares R; von Hafe P
    Porto Biomed J; 2020; 5(6):e108. PubMed ID: 33324783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and therapeutic potential of interactions between human amyloids and viruses.
    Michiels E; Rousseau F; Schymkowitz J
    Cell Mol Life Sci; 2021 Mar; 78(6):2485-2501. PubMed ID: 33244624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the prevalence of Hepatitis C virus infection in diabetic patients attending a tertiary health-care facility South-west Nigeria.
    Ndako JA; Owolabi AO; Olisa JA; Akinwumi JA; Dojumo VT; Olatinsu O; Adebayo BA
    BMC Infect Dis; 2020 Sep; 20(1):664. PubMed ID: 32907538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis.
    Graf C; Welzel T; Bogdanou D; Vermehren J; Beckel A; Bojunga J; Friedrich-Rust M; Dietz J; Kubesch A; Mondorf A; Fischer S; Lutz T; Stoffers P; Herrmann E; Poynard T; Zeuzem S; Dultz G; Mihm U
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus.
    da Silva CB; Vieira DA; de Melo LF; Chagas ALS; Gomes AD; de Faria CLL; Teixeira R; de Magalhães Queiroz DM; Rocha GA; Soares MMS; Bezerra JMT; Silva LD
    World J Hepatol; 2020 Apr; 12(4):137-148. PubMed ID: 32685106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.